{"type": "root", "children": [{"type": "p", "children": [{"type": "t", "text": "\nRecent bioinformatics analysis of high-throughput microRNA (miRNA) data in papillary thyroid cancer (PTC) has revealed that MIR6843 is one of a panel of differentially expressed miRNAs distinguishing tumor tissue from non‐tumor tissue. In a study examining the prognostic landscape of PTC, 150 miRNAs were found to be deregulated, and a four‐miRNA signature—including MIR6843—was identified as a reliable predictor of overall survival (OS). This signature effectively stratified patients into high‐risk and low‐risk categories, underscoring the potential of these miRNAs as prognostic biomarkers."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "1"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nSpecifically, although the precise biological mechanisms of MIR6843 require further elucidation, its inclusion in the prognostic signature suggests that it may modulate pathways involved in tumor aggressiveness and progression. The four‐miRNA model, with an impressive area under the curve (AUC) of 0.886 for 5-year survival prediction, was shown to be an independent predictor of patient outcome after multivariate analysis. This finding highlights MIR6843’s potential clinical importance in risk stratification and decision-making for PTC management."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "1"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nTogether, these results support the emerging role of novel miRNA biomarkers, such as MIR6843, in the prognostication of PTC. The study paves the way for further research aimed at fully characterizing the molecular functions of MIR6843 and assessing its utility as a therapeutic target or an adjunct in the design of personalized treatment strategies."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "1"}]}, {"type": "t", "text": "\n"}]}, {"type": "rg", "children": [{"type": "r", "ref": 1, "children": [{"type": "t", "text": "Xiong Chengfeng, Cai Gengming, Zhang Junjia, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MicroRNA signature predicts survival in papillary thyroid carcinoma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Cell Biochem (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/jcb.28966"}], "href": "https://doi.org/10.1002/jcb.28966"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "31099134"}], "href": "https://pubmed.ncbi.nlm.nih.gov/31099134"}]}]}]}